temozolomide
- Product NDC
- 70771-1093
- 11-digit product format
- 707711093
- Labeler code
- 70771
- Product ID
- 70771-1093_84b259e3-d098-4384-8e3d-d498ba589408
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- temozolomide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA206750
- Marketing category
- ANDA
- Marketing start
- 2017-10-26
- Marketing end
- 0000-00-00
- Substance
- TEMOZOLOMIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Alkylating Activity [MoA], Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70771-1093-6 | 70771109306 | 5 CAPSULE in 1 BOTTLE (70771-1093-6) | 5 capsule | 2017-10-26 | 0000-00-00 | No | No | Current |
| 70771-1093-7 | 70771109307 | 14 CAPSULE in 1 BOTTLE (70771-1093-7) | 14 capsule | 2017-10-26 | 0000-00-00 | No | No | Current |